112 related articles for article (PubMed ID: 9685925)
1. Biodegradable implants for the delivery of veterinary vaccines: design, manufacture and antibody responses in sheep.
Walduck AK; Opdebeeck JP; Benson HE; Prankerd R
J Control Release; 1998 Feb; 51(2-3):269-80. PubMed ID: 9685925
[TBL] [Abstract][Full Text] [Related]
2. Effect of adjuvants on antibody responses of sheep immunised with recombinant pili from Dichelobacter nodosus.
Walduck AK; Opdebeeck JP
Aust Vet J; 1996 Dec; 74(6):451-5. PubMed ID: 9006863
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulatory lipid implants containing Quil-A and DC-cholesterol.
Myschik J; McBurney WT; Rades T; Hook S
Int J Pharm; 2008 Nov; 363(1-2):91-8. PubMed ID: 18692555
[TBL] [Abstract][Full Text] [Related]
4. Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep.
Rothel JS; Boyle DB; Both GW; Pye AD; Waterkeyn JG; Wood PR; Lightowlers MW
Parasite Immunol; 1997 May; 19(5):221-7. PubMed ID: 9194099
[TBL] [Abstract][Full Text] [Related]
5. Melatonin enhances responsiveness to Dichelobacter nodosus vaccine in sheep and increases peripheral blood CD4 T lymphocytes and IgG-expressing B lymphocytes.
Ramos A; Míguez MP; Morgado S; Sanchez-Correa B; Gordillo JJ; Casado JG; Tarazona R; Regodón S
Vet Immunol Immunopathol; 2018 Dec; 206():1-8. PubMed ID: 30502907
[TBL] [Abstract][Full Text] [Related]
6. Antibody response in sheep following immunization with Streptococcus bovis in different adjuvants.
Shu Q; Bir SH; Gill HS; Duan E; Xu Y; Hiliard ; Rowe JB
Vet Res Commun; 2001 Jan; 25(1):43-54. PubMed ID: 11214671
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of sheep with Quil-A® adjuvant expands the antibody repertoire to the Fasciola MF6p/FhHDM-1 antigen and administered together impair the growth and antigen release of flukes.
Orbegozo-Medina RA; Martínez-Sernández V; González-Warleta M; Castro-Hermida JA; Mezo M; Ubeira FM
Vaccine; 2018 Apr; 36(15):1949-1957. PubMed ID: 29525280
[TBL] [Abstract][Full Text] [Related]
8. Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part II: In vivo evaluation.
Myschik J; McBurney WT; Hennessy T; Phipps-Green A; Rades T; Hook S
J Drug Target; 2008 Apr; 16(3):224-32. PubMed ID: 18365884
[TBL] [Abstract][Full Text] [Related]
9. Protective antibody titres and antigenic competition in multivalent Dichelobacter nodosus fimbrial vaccines using characterised rDNA antigens.
Raadsma HW; O'Meara TJ; Egerton JR; Lehrbach PR; Schwartzkoff CL
Vet Immunol Immunopathol; 1994 Mar; 40(3):253-74. PubMed ID: 7909183
[TBL] [Abstract][Full Text] [Related]
10. Injectable silicone implants as vaccine delivery vehicles.
Lofthouse SA; Kajihara M; Nagahara S; Nash A; Barcham GJ; Sedgmen B; Brandon MR; Sano A
Vaccine; 2002 Mar; 20(13-14):1725-32. PubMed ID: 11906759
[TBL] [Abstract][Full Text] [Related]
11. Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part I: Physicochemical characterisation.
Myschik J; Eberhardt F; Rades T; Hook S
J Drug Target; 2008 Apr; 16(3):213-23. PubMed ID: 18365883
[TBL] [Abstract][Full Text] [Related]
12. A recombinant subunit vaccine for bovine RSV and Histophilus somni protects calves against dual pathogen challenge.
Gershwin LJ; Behrens NE; McEligot HA; Carvallo-Chaigneau FR; Crum LT; Gunnarson BM; Corbeil LB
Vaccine; 2017 Apr; 35(15):1954-1963. PubMed ID: 28274639
[TBL] [Abstract][Full Text] [Related]
13. Quil A and ISCOMs as adjuvants for midgut membrane antigens of Boophilus microplus.
Jackson LA; Opdebeeck JP
Appl Parasitol; 1994 Jun; 35(2):87-98. PubMed ID: 8087157
[TBL] [Abstract][Full Text] [Related]
14. Effect on systemic antibody concentrations of topical application of choleratoxin to skin of sheep.
Cope RB; Colditz IG
Aust Vet J; 2000 Feb; 78(2):121-3. PubMed ID: 10736674
[TBL] [Abstract][Full Text] [Related]
15. Pasteurella multocida inactivated with ferric chloride and adjuvanted with bacterial DNA is a potent and efficacious vaccine in Balb/c mice.
Homayoon M; Tahamtan Y; Kargar M; Hosseini SMH; Akhavan Sepahy A
J Med Microbiol; 2018 Sep; 67(9):1383-1390. PubMed ID: 30016232
[TBL] [Abstract][Full Text] [Related]
16. Antibody and cytokine responses in efferent lymph following vaccination with different adjuvants.
Rothel JS; Corner LA; Lightowlers MW; Seow HF; McWaters P; Entrican G; Wood PR
Vet Immunol Immunopathol; 1998 May; 63(1-2):167-83. PubMed ID: 9656452
[TBL] [Abstract][Full Text] [Related]
17. Impact of implant composition of twin-screw extruded lipid implants on the release behavior.
Even MP; Bobbala S; Kooi KL; Hook S; Winter G; Engert J
Int J Pharm; 2015 Sep; 493(1-2):102-10. PubMed ID: 26188320
[TBL] [Abstract][Full Text] [Related]
18. The use of melatonin as a vaccine agent.
Regodón S; Martín-Palomino P; Fernández-Montesinos R; Herrera JL; Carrascosa-Salmoral MP; Píriz S; Vadillo S; Guerrero JM; Pozo D
Vaccine; 2005 Nov; 23(46-47):5321-7. PubMed ID: 16055232
[TBL] [Abstract][Full Text] [Related]
19. Effect of pilus dose and type of Freund's adjuvant on the antibody and protective responses of vaccinated sheep to Bacteroides nodosus.
Stewart DJ; Clark BL; Peterson JE; Griffiths DA; Smith EF; O'Donnell IJ
Res Vet Sci; 1983 Sep; 35(2):130-7. PubMed ID: 6138825
[TBL] [Abstract][Full Text] [Related]
20. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.
Even MP; Young K; Winter G; Hook S; Engert J
Eur J Pharm Biopharm; 2014 Jul; 87(2):338-46. PubMed ID: 24607791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
